Total liabilities · 2013–2025
Akebia Therapeutics total liabilities
$344M+27.5% · FY2025
Akebia Therapeutics (AKBA) reported $344M in total liabilities for fiscal 2025, +27.5% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $344M | +27.5% | Open → |
| FY20242024-12-31 | $270M | −0.9% | Open → |
| FY20232023-12-31 | $272M | −22.4% | Open → |
| FY20222022-12-31 | $351M | −23.0% | Open → |
| FY20212021-12-31 | $455M | +14.8% | Open → |
| FY20202020-12-31 | $397M | +5.3% | Open → |
| FY20192019-12-31 | $376M | +4.4% | Open → |
| FY20182018-12-31 | $361M | +49.2% | Open → |
| FY20172017-12-31 | $242M | +4.1% | Open → |
| FY20162016-12-31 | $232M | +1,843.5% | Open → |
| FY20152015-12-31 | $11.9M | +72.6% | Open → |
| FY20142014-12-31 | $6.9M | +76.9% | Open → |
| FY20132013-12-31 | $3.9M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +45.2%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Akebia Therapeutics total liabilities |url=https://companiesranked.com/en/company/akebia-therapeutics/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Akebia Therapeutics total liabilities. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/total-liabilitiesBibTeX
@misc{companiesranked-en-company-akebia-therapeutics-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Akebia Therapeutics total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001517022-26-000051 · August 5, 2026
{{cite web |title=Akebia Therapeutics total liabilities — 10-Q (0001517022-26-000051) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000051/akba-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.